Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach.

Kramer RM, Archer MC, Orr MT, Dubois Cauwelaert N, Beebe EA, Huang PD, Dowling QM, Schwartz AM, Fedor DM, Vedvick TS, Fox CB.

Int J Nanomedicine. 2018 Jun 26;13:3689-3711. doi: 10.2147/IJN.S159839. eCollection 2018.

2.

The Value of Using Multiple Metrics to Evaluate PCB Exposure.

Archer MC, Harwood AD, Nutile SA, Hartz KEH, Mills MA, Garvey JE, Lydy MJ.

Arch Environ Contam Toxicol. 2018 Apr;74(3):361-371. doi: 10.1007/s00244-017-0418-5. Epub 2017 Jun 10.

PMID:
28601932
3.

Lyophilization of an Adjuvanted Mycobacterium tuberculosis Vaccine in a Single-Chamber Pharmaceutical Cartridge.

Barnes V L, Fedor DM, Williams S, Dowling QM, Archer MC, Cloutier S, Parker S, Vedvick TS, Fox CB, Kramer RM.

AAPS PharmSciTech. 2017 Aug;18(6):2077-2084. doi: 10.1208/s12249-016-0688-7. Epub 2016 Dec 20.

PMID:
28000085
4.

The interplay between cell signalling and the mevalonate pathway in cancer.

Mullen PJ, Yu R, Longo J, Archer MC, Penn LZ.

Nat Rev Cancer. 2016 Nov;16(11):718-731. doi: 10.1038/nrc.2016.76. Epub 2016 Aug 26. Review.

PMID:
27562463
5.

Risk factors for colorectal cancer in man induce aberrant crypt foci in rats: Preliminary findings.

Yang K, Fard S, Furrer R, Archer MC, Bruce WR, Lip H, Mehta R, O'Brien PJ, Giacca A, Ward WE, Femia AP, Caderni G, Medline A, Banks K.

Nutr Cancer. 2016;68(1):94-104. doi: 10.1080/01635581.2016.1115098. Epub 2015 Dec 28.

6.

MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.

Menezes ME, Shen XN, Das SK, Emdad L, Guo C, Yuan F, Li YJ, Archer MC, Zacksenhaus E, Windle JJ, Subler MA, Ben-David Y, Sarkar D, Wang XY, Fisher PB.

Oncotarget. 2015 Nov 10;6(35):36928-42. doi: 10.18632/oncotarget.6047.

7.

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice.

Li YJ, Liu G, Xia L, Xiao X, Liu JC, Menezes ME, Das SK, Emdad L, Sarkar D, Fisher PB, Archer MC, Zacksenhaus E, Ben-David Y.

Oncotarget. 2015 Nov 10;6(35):36943-54. doi: 10.18632/oncotarget.6046.

8.

Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity.

Hopperton KE, Duncan RE, Bazinet RP, Archer MC.

Exp Cell Res. 2014 Jan 15;320(2):302-10. doi: 10.1016/j.yexcr.2013.10.016. Epub 2013 Nov 4.

PMID:
24200503
9.

mda-7/IL-24 expression inhibits breast cancer through upregulation of growth arrest-specific gene 3 (gas3) and disruption of β1 integrin function.

Li YJ, Liu G, Li Y, Vecchiarelli-Federico LM, Liu JC, Zacksenhaus E, Shan SW, Yang BB, Li Q, Dash R, Fisher PB, Archer MC, Ben-David Y.

Mol Cancer Res. 2013 Jun;11(6):593-603. doi: 10.1158/1541-7786.MCR-12-0496. Epub 2013 Mar 6.

10.

Role of sp transcription factors in the regulation of cancer cell metabolism.

Archer MC.

Genes Cancer. 2011 Jul;2(7):712-9. doi: 10.1177/1947601911423029.

11.

Inhibition of fatty acid synthase and Sp1 expression by 3,3'-diindolylmethane in human breast cancer cells.

Saati GE, Archer MC.

Nutr Cancer. 2011;63(5):790-4. doi: 10.1080/01635581.2011.570896. Epub 2011 Jun 22.

PMID:
21767081
12.

The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum.

Esfahani A, Kendall CW, Bashyam B, Archer MC, Jenkins DJ.

In Vitro Cell Dev Biol Anim. 2010 Dec;46(10):856-62. doi: 10.1007/s11626-010-9351-x. Epub 2010 Oct 7.

PMID:
20927603
13.

Diabetes and cancer: a consensus report.

Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D.

Diabetes Care. 2010 Jul;33(7):1674-85. doi: 10.2337/dc10-0666.

14.

Diabetes and cancer: a consensus report.

Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D.

CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21. doi: 10.3322/caac.20078. Epub 2010 Jun 16.

15.
16.

Ezetimibe reverses the inhibitory effects of dietary cholesterol on mammary tumorigenesis in rats.

McNamara E, Archer MC.

Int J Cancer. 2010 Aug 15;127(4):791-5. doi: 10.1002/ijc.25089.

17.

Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells.

Lu S, Archer MC.

Int J Cancer. 2010 Jan 15;126(2):416-25. doi: 10.1002/ijc.24761.

18.

Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4.

Xuan W, Li YJ, Liu G, Ben-David Y, Archer MC.

Mol Cancer Res. 2009 Mar;7(3):433-42. doi: 10.1158/1541-7786.MCR-08-0252. Epub 2009 Mar 3.

19.

Fatty acid synthase is over-expressed in large aberrant crypt foci in rats treated with azoxymethane.

Lau DS, Archer MC.

Int J Cancer. 2009 Jun 1;124(11):2750-3. doi: 10.1002/ijc.24242.

21.

Adiponectin is a negative regulator of bone mineral and bone strength in growing mice.

Ealey KN, Kaludjerovic J, Archer MC, Ward WE.

Exp Biol Med (Maywood). 2008 Dec;233(12):1546-53. doi: 10.3181/0806-RM-192. Epub 2008 Oct 10.

PMID:
18849538
22.

Dehydroalanine and lysinoalanine in thermolyzed casein do not promote colon cancer in the rat.

Corpet DE, Taché S, Archer MC, Bruce WR.

Food Chem Toxicol. 2008 Sep;46(9):3037-42. doi: 10.1016/j.fct.2008.06.002. Epub 2008 Jun 10.

23.
24.

Development of aberrant crypt foci in the colons of ob/ob and db/db mice: evidence that leptin is not a promoter.

Ealey KN, Lu S, Archer MC.

Mol Carcinog. 2008 Sep;47(9):667-77. doi: 10.1002/mc.20419.

PMID:
18240295
25.

Reduced susceptibility of muscle-specific insulin receptor knockout mice to colon carcinogenesis.

Ealey KN, Lu S, Lau D, Archer MC.

Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G679-86. doi: 10.1152/ajpgi.00526.2007. Epub 2008 Jan 3.

26.

Colon carcinogenesis in liver-specific IGF-I-deficient (LID) mice.

Ealey KN, Xuan W, Lu S, Archer MC.

Int J Cancer. 2008 Jan 15;122(2):472-6.

27.

Statins and cancer.

Duncan RE, El-Sohemy A, Archer MC.

Epidemiology. 2007 Jul;18(4):520; author reply 520-1. No abstract available.

PMID:
17568229
28.

Celecoxib decreases fatty acid synthase expression via down-regulation of c-Jun N-terminal kinase-1.

Lu S, Archer MC.

Exp Biol Med (Maywood). 2007 May;232(5):643-53.

PMID:
17463161
29.

Statins and the risk of cancer.

Duncan RE, El-Sohemy A, Archer MC.

JAMA. 2006 Jun 21;295(23):2720; author reply 2721-2. No abstract available.

PMID:
16788123
30.

Bone abnormalities in adolescent leptin-deficient mice.

Ealey KN, Fonseca D, Archer MC, Ward WE.

Regul Pept. 2006 Sep 11;136(1-3):9-13. Epub 2006 Jun 9.

PMID:
16764953
31.

Farnesol induces thyroid hormone receptor (THR) beta1 but inhibits THR-mediated signaling in MCF-7 human breast cancer cells.

Duncan RE, Archer MC.

Biochem Biophys Res Commun. 2006 Apr 28;343(1):239-43. Epub 2006 Mar 3.

PMID:
16540091
32.

The case for strategic international alliances to harness nutritional genomics for public and personal health.

Kaput J, Ordovas JM, Ferguson L, van Ommen B, Rodriguez RL, Allen L, Ames BN, Dawson K, German B, Krauss R, Malyj W, Archer MC, Barnes S, Bartholomew A, Birk R, van Bladeren P, Bradford KJ, Brown KH, Caetano R, Castle D, Chadwick R, Clarke S, Clément K, Cooney CA, Corella D, Manica da Cruz IB, Daniel H, Duster T, Ebbesson SO, Elliott R, Fairweather-Tait S, Felton J, Fenech M, Finley JW, Fogg-Johnson N, Gill-Garrison R, Gibney MJ, Gillies PJ, Gustafsson JA, Hartman JL 4th, He L, Hwang JK, Jais JP, Jang Y, Joost H, Junien C, Kanter M, Kibbe WA, Koletzko B, Korf BR, Kornman K, Krempin DW, Langin D, Lauren DR, Ho Lee J, Leveille GA, Lin SJ, Mathers J, Mayne M, McNabb W, Milner JA, Morgan P, Muller M, Nikolsky Y, van der Ouderaa F, Park T, Pensel N, Perez-Jimenez F, Poutanen K, Roberts M, Saris WH, Schuster G, Shelling AN, Simopoulos AP, Southon S, Tai ES, Towne B, Trayhurn P, Uauy R, Visek WJ, Warden C, Weiss R, Wiencke J, Winkler J, Wolff GL, Zhao-Wilson X, Zucker JD.

Br J Nutr. 2005 Nov;94(5):623-32. Review.

33.

Statins and cancer development.

Duncan RE, El-Sohemy A, Archer MC.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1897-8. Review.

34.

Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin.

Duncan RE, El-Sohemy A, Archer MC.

Cancer Lett. 2005 Jun 28;224(2):221-8. Epub 2004 Dec 16.

PMID:
15914273
35.

Effects of dietary folate on the development and progression of mammary tumors in rats.

Kotsopoulos J, Medline A, Renlund R, Sohn KJ, Martin R, Hwang SW, Lu S, Archer MC, Kim YI.

Carcinogenesis. 2005 Sep;26(9):1603-12. Epub 2005 May 11.

PMID:
15888495
37.
38.

Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.

Duncan RE, Lau D, El-Sohemy A, Archer MC.

Biochem Pharmacol. 2004 Nov 1;68(9):1739-47. Erratum in: Biochem Pharmacol. 2005 Jan 15;69(2):361.

PMID:
15450939
39.

Delivery of mevalonate to murine extrahepatic tissues via mini-osmotic pumps.

Duncan RE, El-Sohemy A, Archer MC.

J Pharmacol Toxicol Methods. 2004 Sep-Oct;50(2):139-43.

PMID:
15385088
40.

Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer.

Lu S, Archer MC.

Carcinogenesis. 2005 Jan;26(1):153-7. Epub 2004 Sep 9.

PMID:
15358634
41.

Creatine: a safety concern.

Archer MC.

Toxicol Lett. 2004 Sep 25;152(3):275. No abstract available.

PMID:
15331137
42.

The use of creatine to enhance athletic performance.

Archer MC.

Nutrition. 2004 Sep;20(9):841. No abstract available.

PMID:
15325697
43.

Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats.

De Miglio MR, Pascale RM, Simile MM, Muroni MR, Virdis P, Kwong KM, Wong LK, Bosinco GM, Pulina FR, Calvisi DF, Frau M, Wood GA, Archer MC, Feo F.

Int J Cancer. 2004 Aug 10;111(1):9-16.

44.
46.
47.

Effects of dietary conjugated linoleic acid on the expression of uncoupling proteins in mice and rats.

Ealey KN, El-Sohemy A, Archer MC.

Lipids. 2002 Sep;37(9):853-61.

PMID:
12458620
48.
49.
50.

Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes.

Wood GA, Korkola JE, Archer MC.

Carcinogenesis. 2002 Jan;23(1):1-9. Review.

PMID:
11756217

Supplemental Content

Loading ...
Support Center